FDA asks how to improve existing Regulations
The U.S. Food and Drug Administration FDA announced that the agency is formally asking for submissions on how to improve existing regulations. FDA expects that retrospective reviews like this would help FDA focus on how to improve regulations.
- Where are regulations ineffective?
- Do regulations address current public health challenges?
- Is there a need to update regulations?
- Can regulations be revised in ways that make them less burdensome without making them less effective?
- Are there regulatory requirements that are redundant, inconsistent or needlessly overlap?
To get more information, go to the FDA Transparency Blog.
Related GMP News
14.01.2026Could a change of ownership be relevant to GMP?
14.01.2026New Ph. Eur. Publication Schedule
07.01.2026Is QP Certification required when Products do not enter EU Territory?
17.12.2025EU Reaches Landmark on Reform of Pharmaceutical Legislation
12.11.2025GMP for Veterinary Products: Implementing Regulations published